The Medicines for Human Use (Clinical Trials) Regulations 2004

2.  Subject to paragraph 6, if the licensing authority propose—U.K.

(a)not to grant an authorisation;

(b)to grant an authorisation other than in accordance with the application; or

(c)to revoke, vary or suspend an authorisation,

the licensing authority shall notify the applicant or holder accordingly.